Controlling Antimicrobial Resistance in the Hospital

Infectious Disease Clinics of North America

Volumn 23, Issue 4, 2009, Pages 847-864

  Anderson, Deverick J ^a   Kaye, Keith S ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antibiotic stewardship; Antimicrobial resistance; Hospital acquired infection; Infection control; Prevention; Surveillance

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CEPHALOSPORIN DERIVATIVE; CHLORHEXIDINE; POLYMYXIN;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; CLEANING; CLOSTRIDIUM DIFFICILE INFECTION; DECISION SUPPORT SYSTEM; DEVICE; DIARRHEA; DISEASE SURVEILLANCE; DISINFECTION; DRUG CONTROL; ENTEROBACTERIACEAE INFECTION; ERADICATION THERAPY; EVIDENCE BASED PRACTICE; HAND WASHING; HEALTH CARE PERSONNEL; HIGH RISK PATIENT; HOSPITAL CARE; HOSPITAL HYGIENE; HUMAN; INFECTION CONTROL; INSTRUMENT STERILIZATION; INVASIVE PROCEDURE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL COLONIZATION; NAUSEA; PROTECTIVE CLOTHING; RASH; REVIEW; SCREENING; SKIN DECONTAMINATION; STRATEGIC PLANNING; VANCOMYCIN RESISTANT ENTEROCOCCUS; VENTILATOR ASSOCIATED PNEUMONIA; VOMITING;

ANTI-BACTERIAL AGENTS; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; HOSPITALS; HUMANS; INFECTION CONTROL;

EID: 70350714129     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idc.2009.06.005     Document Type: Review

References (111)

1. Siegel J.D., Rhinehart E., Jackson M., et al. Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control 35 10 Suppl 2 (2007) S165-S193
2. Boyce J.M., and Pittet D. Guideline for hand hygiene in health-care settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Society for Healthcare Epidemiology of America/Association for Professionals in Infection Control/Infectious Diseases Society of America. MMWR Recomm Rep 51 RR-16 (2002) 1-45 quiz CE41-44
3. Moolenaar R.L., Crutcher J.M., San Joaquin V.H., et al. A prolonged outbreak of Pseudomonas aeruginosa in a neonatal intensive care unit: did staff fingernails play a role in disease transmission?. Infect Control Hosp Epidemiol 21 2 (2000) 80-85
4. Pottinger J., Burns S., and Manske C. Bacterial carriage by artificial versus natural nails. Am J Infect Control 17 6 (1989) 340-344
5. Byers K.E., Anglim A.M., Anneski C.J., et al. Duration of colonization with vancomycin-resistant Enterococcus. Infect Control Hosp Epidemiol 23 4 (2002) 207-211
6. Puzniak L.A., Leet T., Mayfield J., et al. To gown or not to gown: the effect on acquisition of vancomycin-resistant enterococci. Clin Infect Dis 35 1 (2002) 18-25
7. Srinivasan A., Dick J.D., and Perl T.M. Vancomycin resistance in staphylococci. Clin Microbiol Rev 15 3 (2002) 430-438
8. Kirkland K.B., and Weinstein J.M. Adverse effects of contact isolation. Lancet 354 9185 (1999) 1177-1178
9. Saint S., Higgins L.A., Nallamothu B.K., et al. Do physicians examine patients in contact isolation less frequently? A brief report. Am J Infect Control 31 6 (2003) 354-356
10. Stelfox H.T., Bates D.W., and Redelmeier D.A. Safety of patients isolated for infection control. JAMA 290 14 (2003) 1899-1905
11. Karchmer T.B., Durbin L.J., Simonton B.M., et al. Cost-effectiveness of active surveillance cultures and contact/droplet precautions for control of methicillin-resistant Staphylococcus aureus. J Hosp Infect 51 2 (2002) 126-132
12. West T.E., Guerry C., Hiott M., et al. Effect of targeted surveillance for control of methicillin-resistant Staphylococcus aureus in a community hospital system. Infect Control Hosp Epidemiol 27 3 (2006) 233-238
13. Huang S.S., Yokoe D.S., Hinrichsen V.L., et al. Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis 43 8 (2006) 971-978
14. Troche G., Joly L.M., Guibert M., et al. Detection and treatment of antibiotic-resistant bacterial carriage in a surgical intensive care unit: a 6-year prospective survey. Infect Control Hosp Epidemiol 26 2 (2005) 161-165
15. Nijssen S., Bonten M.J., and Weinstein R.A. Are active microbiological surveillance and subsequent isolation needed to prevent the spread of methicillin-resistant Staphylococcus aureus?. Clin Infect Dis 40 3 (2005) 405-409
16. Huang S.S., Rifas-Shiman S.L., Warren D.K., et al. Improving methicillin-resistant Staphylococcus aureus surveillance and reporting in intensive care units. J Infect Dis 195 3 (2007) 330-338
17. Huang S.S., Rifas-Shiman S.L., Pottinger J.M., et al. Improving the assessment of vancomycin-resistant enterococci by routine screening. J Infect Dis 195 3 (2007) 339-346
18. McGinigle K.L., Gourlay M.L., and Buchanan I.B. The use of active surveillance cultures in adult intensive care units to reduce methicillin-resistant Staphylococcus aureus-related morbidity, mortality, and costs: a systematic review. Clin Infect Dis 46 11 (2008) 1717-1725
19. Robicsek A., Beaumont J.L., Paule S.M., et al. Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Ann Intern Med 148 6 (2008) 409-418
20. Lautenbach E. Expanding the universe of methicillin-resistant Staphylococcus aureus prevention. Ann Intern Med 148 6 (2008) 474-476
21. Harbarth S., Fankhauser C., Schrenzel J., et al. Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. JAMA 299 10 (2008) 1149-1157
22. Huang S.S., and Platt R. Risk of methicillin-resistant Staphylococcus aureus infection after previous infection or colonization. Clin Infect Dis 36 3 (2003) 281-285
23. Harbarth S., Cosgrove S., and Carmeli Y. Effects of antibiotics on nosocomial epidemiology of vancomycin-resistant enterococci. Antimicrob Agents Chemother 46 6 (2002) 1619-1628
24. Kauffman C.A., Terpenning M.S., He X., et al. Attempts to eradicate methicillin-resistant Staphylococcus aureus from a long-term-care facility with the use of mupirocin ointment. Am J Med 94 4 (1993) 371-378
25. Simor A.E., Phillips E., McGeer A., et al. Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus colonization. Clin Infect Dis 44 2 (2007) 178-185
26. Loeb M., Main C., Walker-Dilks C., et al. Antimicrobial drugs for treating methicillin-resistant Staphylococcus aureus colonization. Cochrane Database Syst Rev 4 (2003) CD003340
27. Miller M.A., Dascal A., Portnoy J., et al. Development of mupirocin resistance among methicillin-resistant Staphylococcus aureus after widespread use of nasal mupirocin ointment. Infect Control Hosp Epidemiol 17 12 (1996) 811-813
28. Mody L., Kauffman C.A., McNeil S.A., et al. Mupirocin-based decolonization of Staphylococcus aureus carriers in residents of 2 long-term care facilities: a randomized, double-blind, placebo-controlled trial. Clin Infect Dis 37 11 (2003) 1467-1474
29. Vernon M.O., Hayden M.K., Trick W.E., et al. Chlorhexidine gluconate to cleanse patients in a medical intensive care unit: the effectiveness of source control to reduce the bioburden of vancomycin-resistant enterococci. Arch Intern Med 166 3 (2006) 306-312
30. Milstone A.M., Passaretti C.L., and Perl T.M. Chlorhexidine: expanding the armamentarium for infection control and prevention. Clin Infect Dis 46 2 (2008) 274-281
31. Haley R.W., Cushion N.B., Tenover F.C., et al. Eradication of endemic methicillin-resistant Staphylococcus aureus infections from a neonatal intensive care unit. J Infect Dis 171 3 (1995) 614-624
32. Kotilainen P., Routamaa M., Peltonen R., et al. Eradication of methicillin-resistant Staphylococcus aureus from a health center ward and associated nursing home. Arch Intern Med 161 6 (2001) 859-863
33. Jochimsen E.M., Fish L., Manning K., et al. Control of vancomycin-resistant enterococci at a community hospital: efficacy of patient and staff cohorting. Infect Control Hosp Epidemiol 20 2 (1999) 106-109
34. Rupp M.E., Marion N., Fey P.D., et al. Outbreak of vancomycin-resistant Enterococcus faecium in a neonatal intensive care unit. Infect Control Hosp Epidemiol 22 5 (2001) 301-303
35. Lucet J.C., Decre D., Fichelle A., et al. Control of a prolonged outbreak of extended-spectrum beta-lactamase-producing enterobacteriaceae in a university hospital. Clin Infect Dis 29 6 (1999) 1411-1418
36. Schwaber MJ, Israel pCRE Working Group. Infection control at the national level: containment of an outbreak of carbapenem-resistant Klebsiella pneumoniae (CRKP) in Israeli hospitals. Paper presented at: Proceedings of 48th Annual Interscience Conference on Anitmicrobial Agents and Chemotherapy/Infectious Disease Society of America 46th Annual Meeting; October 27, 2008; Washington, DC.
37. Mangram A.J., Horan T.C., Pearson M.L., et al. Guideline for prevention of surgical site infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control 27 2 (1999) 97-132 quiz 133-4; [discussion: 196]
38. Bratzler D.W., and Hunt D.R. The surgical infection prevention and surgical care improvement projects: national initiatives to improve outcomes for patients having surgery. Clin Infect Dis 43 3 (2006) 322-330
39. Bratzler D.W., and Houck P.M. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis 38 12 (2004) 1706-1715
40. Klevens R.M., Morrison M.A., Nadle J., et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298 15 (2007) 1763-1771
41. Bergmans D.C., Bonten M.J., Gaillard C.A., et al. Prevention of ventilator-associated pneumonia by oral decontamination: a prospective, randomized, double-blind, placebo-controlled study. Am J Respir Crit Care Med 164 3 (2001) 382-388
42. Chan E.Y., Ruest A., Meade M.O., et al. Oral decontamination for prevention of pneumonia in mechanically ventilated adults: systematic review and meta-analysis. BMJ 334 7599 (2007) 889
43. D'Amico R., Pifferi S., Leonetti C., et al. Effectiveness of antibiotic prophylaxis in critically ill adult patients: systematic review of randomised controlled trials. BMJ 316 7140 (1998) 1275-1285
44. de Jonge E., Schultz M.J., Spanjaard L., et al. Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial. Lancet 362 9389 (2003) 1011-1016
45. Sanchez Garcia M., Cambronero Galache J.A., Lopez Diaz J., et al. Effectiveness and cost of selective decontamination of the digestive tract in critically ill intubated patients: a randomized, double-blind, placebo-controlled, multicenter trial. Am J Respir Crit Care Med 158 3 (1998) 908-916
46. Silvestri L., van Saene H.K., Casarin A., et al. Impact of selective decontamination of the digestive tract on carriage and infection due to gram-negative and gram-positive bacteria: a systematic review of randomised controlled trials. Anaesth Intensive Care 36 3 (2008) 324-338
47. de Smet A.M., Kluytmans J.A., Cooper B.S., et al. Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med 360 1 (2009) 20-31
48. Coffin S.E., Klompas M., Classen D., et al. Strategies to prevent ventilator-associated pneumonia in acute care hospitals. Infect Control Hosp Epidemiol 29 Suppl 1 (2008) S31-S40
49. Improvement IfH. A resource from the Institute of Healthcare Improvement. Available at:. www.ihi.org Accessed January 31, 2007
50. Anderson D.J., Kaye K.S., Classen D., et al. Strategies to prevent surgical site infections in acute care hospitals. Infect Control Hosp Epidemiol 29 Suppl 1 (2008) S51-S61
51. Berenholtz S.M., Pronovost P.J., Lipsett P.A., et al. Eliminating catheter-related bloodstream infections in the intensive care unit. Crit Care Med 32 10 (2004) 2014-2020
52. Marschall J., Mermel L.A., Classen D., et al. Strategies to prevent central line-associated bloodstream infections in acute care hospitals. Infect Control Hosp Epidemiol 29 Suppl 1 (2008) S22-S30
53. Pronovost P., Needham D., Berenholtz S., et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 355 26 (2006) 2725-2732
54. Tsuchida T., Makimoto K., Toki M., et al. The effectiveness of a nurse-initiated intervention to reduce catheter-associated bloodstream infections in an urban acute hospital: an intervention study with before and after comparison. Int J Nurs Stud 44 8 (2007) 1324-1333
55. Centers for Disease Control. Pseudomonas aeruginosa infections associated with transrectal ultrasound-guided prostate biopsies-Georgia, 2005. MMWR Morb Mortal Wkly Rep 55 28 (2006) 776-777
56. Meyers H., Brown-Elliott B.A., Moore D., et al. An outbreak of Mycobacterium chelonae infection following liposuction. Clin Infect Dis 34 11 (2002) 1500-1507
57. Spach D.H., Silverstein F.E., and Stamm W.E. Transmission of infection by gastrointestinal endoscopy and bronchoscopy. Ann Intern Med 118 2 (1993) 117-128
58. Weber D.J., and Rutala W.A. Lessons from outbreaks associated with bronchoscopy. Infect Control Hosp Epidemiol 22 7 (2001) 403-408
59. Rutala W.A., Weber D.J., and Healthcare Infection Control Practices Advisory Committee (HICPAC). Guideline for disinfection and sterilization in healthcare facilities. 2008. Available at:. http://www.cdc.gov/ncidod/dhqp/pdf/guidelines/Disinfection_Nov_2008.pdf Accessed December 15, 2008
60. Boyce J.M., Potter-Bynoe G., Chenevert C., et al. Environmental contamination due to methicillin-resistant Staphylococcus aureus: possible infection control implications. Infect Control Hosp Epidemiol 18 9 (1997) 622-627
61. Martinez J.A., Ruthazer R., Hansjosten K., et al. Role of environmental contamination as a risk factor for acquisition of vancomycin-resistant enterococci in patients treated in a medical intensive care unit. Arch Intern Med 163 16 (2003) 1905-1912
62. Alfa M.J., Dueck C., Olson N., et al. UV-visible marker confirms that environmental persistence of Clostridium difficile spores in toilets of patients with C. difficile-associated diarrhea is associated with lack of compliance with cleaning protocols. BMC Infect Dis 8 (2008) 1-7
63. Samore M.H., Venkataraman L., DeGirolami P.C., et al. Clinical and molecular epidemiology of sporadic and clustered cases of nosocomial Clostridium difficile diarrhea. Am J Med 100 1 (1996) 32-40
64. Bradley S.F., Terpenning M.S., Ramsey M.A., et al. Methicillin-resistant Staphylococcus aureus: colonization and infection in a long-term care facility. Ann Intern Med 115 6 (1991) 417-422
65. Maki D.G., Alvarado C.J., Hassemer C.A., et al. Relation of the inanimate hospital environment to endemic nosocomial infection. N Engl J Med 307 25 (1982) 1562-1566
66. Sehulster L., and Chinn R.Y. Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep 52 RR-10 (2003) 1-42
67. Hota B. Contamination, disinfection, and cross-colonization: are hospital surfaces reservoirs for nosocomial infection?. Clin Infect Dis 39 8 (2004) 1182-1189
68. McMullen K.M., Zack J., Coopersmith C.M., et al. Use of hypochlorite solution to decrease rates of Clostridium difficile-associated diarrhea. Infect Control Hosp Epidemiol 28 2 (2007) 205-207
69. Dellit T.H., Owens R.C., McGowan Jr. J.E., et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 44 2 (2007) 159-177
70. Charbonneau P., Parienti J.J., Thibon P., et al. Fluoroquinolone use and methicillin-resistant Staphylococcus aureus isolation rates in hospitalized patients: a quasi experimental study. Clin Infect Dis 42 6 (2006) 778-784
71. Weber S.G., Gold H.S., Hooper D.C., et al. Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients. Emerg Infect Dis 9 11 (2003) 1415-1422
72. Kaye K.S., Cosgrove S., Harris A., et al. Risk factors for emergence of resistance to broad-spectrum cephalosporins among Enterobacter spp. Antimicrob Agents Chemother 45 9 (2001) 2628-2630
73. Kaye K.S., Kanafani Z.A., Dodds A.E., et al. Differential effects of levofloxacin and ciprofloxacin on the risk for isolation of quinolone-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother 50 6 (2006) 2192-2196
74. Madaras-Kelly K.J., Remington R.E., Lewis P.G., et al. Evaluation of an intervention designed to decrease the rate of nosocomial methicillin-resistant Staphylococcus aureus infection by encouraging decreased fluoroquinolone use. Infect Control Hosp Epidemiol 27 2 (2006) 155-169
75. Meyer K.S., Urban C., Eagan J.A., et al. Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins. Ann Intern Med 119 5 (1993) 353-358
76. Rahal J.J., Urban C., Horn D., et al. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA 280 14 (1998) 1233-1237
77. Calil R., Marba S.T., von Nowakonski A., et al. Reduction in colonization and nosocomial infection by multiresistant bacteria in a neonatal unit after institution of educational measures and restriction in the use of cephalosporins. Am J Infect Control 29 3 (2001) 133-138
78. Go E.S., Urban C., Burns J., et al. Clinical and molecular epidemiology of acinetobacter infections sensitive only to polymyxin B and sulbactam. Lancet 344 8933 (1994) 1329-1332
79. Rahal J.J., Urban C., and Segal-Maurer S. Nosocomial antibiotic resistance in multiple gram-negative species: experience at one hospital with squeezing the resistance balloon at multiple sites. Clin Infect Dis 34 4 (2002) 499-503
80. Coleman R.W., Rodondi L.C., Kaubisch S., et al. Cost-effectiveness of prospective and continuous parenteral antibiotic control: experience at the Palo Alto Veterans Affairs Medical Center from 1987 to 1989. Am J Med 90 4 (1991) 439-444
81. White Jr. A.C., Atmar R.L., Wilson J., et al. Effects of requiring prior authorization for selected antimicrobials: expenditures, susceptibilities, and clinical outcomes. Clin Infect Dis 25 2 (1997) 230-239
82. Woodward R.S., Medoff G., Smith M.D., et al. Antibiotic cost savings from formulary restrictions and physician monitoring in a medical-school-affiliated hospital. Am J Med 83 5 (1987) 817-823
83. de Man P., Verhoeven B.A., Verbrugh H.A., et al. An antibiotic policy to prevent emergence of resistant bacilli. Lancet 355 9208 (2000) 973-978
84. Quale J., Landman D., Saurina G., et al. Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci. Clin Infect Dis 23 5 (1996) 1020-1025
85. Burke J.P. Antibiotic resistance: squeezing the balloon?. JAMA 280 14 (1998) 1270-1271
86. Bantar C., Sartori B., Vesco E., et al. A hospitalwide intervention program to optimize the quality of antibiotic use: impact on prescribing practice, antibiotic consumption, cost savings, and bacterial resistance. Clin Infect Dis 37 2 (2003) 180-186
87. Belongia E.A., Knobloch M.J., Kieke B.A., et al. Impact of statewide program to promote appropriate antimicrobial drug use. Emerg Infect Dis 11 6 (2005) 912-920
88. Lomas J., Anderson G.M., Domnick-Pierre K., et al. Do practice guidelines guide practice? The effect of a consensus statement on the practice of physicians. N Engl J Med 321 19 (1989) 1306-1311
89. Ibrahim E.H., Ward S., Sherman G., et al. Experience with a clinical guideline for the treatment of ventilator-associated pneumonia. Crit Care Med 29 6 (2001) 1109-1115
90. Price J., Ekleberry A., Grover A., et al. Evaluation of clinical practice guidelines on outcome of infection in patients in the surgical intensive care unit. Crit Care Med 27 10 (1999) 2118-2124
91. Centers for Disease Control. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 171 4 (2005) 388-416
92. Harbarth S., Garbino J., Pugin J., et al. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med 115 7 (2003) 529-535
93. Hyle E.P., Lipworth A.D., Zaoutis T.E., et al. Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum beta-lactamase-producing enterobacteriaceae: variability by site of infection. Arch Intern Med 165 12 (2005) 1375-1380
94. Briceland L.L., Nightingale C.H., Quintiliani R., et al. Antibiotic streamlining from combination therapy to monotherapy utilizing an interdisciplinary approach. Arch Intern Med 148 9 (1988) 2019-2022
95. Kollef M.H., and Kollef K.E. Antibiotic utilization and outcomes for patients with clinically suspected ventilator-associated pneumonia and negative quantitative BAL culture results. Chest 128 4 (2005) 2706-2713
96. Evans R.S., Pestotnik S.L., Classen D.C., et al. A computer-assisted management program for antibiotics and other antiinfective agents. N Engl J Med 338 4 (1998) 232-238
97. Pestotnik S.L., Classen D.C., Evans R.S., et al. Implementing antibiotic practice guidelines through computer-assisted decision support: clinical and financial outcomes. Ann Intern Med 124 10 (1996) 884-890
98. Koppel R., Metlay J.P., Cohen A., et al. Role of computerized physician order entry systems in facilitating medication errors. JAMA 293 10 (2005) 1197-1203
99. Burke J.P. Maximizing appropriate antibiotic prophylaxis for surgical patients: an update from LDS Hospital, Salt Lake City. Clin Infect Dis 33 Suppl 2 (2001) S78-S83
100. Classen D.C., Pestotnik S.L., Evans R.S., et al. Computerized surveillance of adverse drug events in hospital patients. JAMA 266 20 (1991) 2847-2851
101. Evans R.S., Pestotnik S.L., Classen D.C., et al. Evaluation of a computer-assisted antibiotic-dose monitor. Ann Pharmacother 33 10 (1999) 1026-1031
102. Munson E.L., Diekema D.J., Beekmann S.E., et al. Detection and treatment of bloodstream infection: laboratory reporting and antimicrobial management. J Clin Microbiol 41 1 (2003) 495-497
103. Peterson L.R., Hamilton J.D., Baron E.J., et al. Role of clinical microbiology laboratories in the management and control of infectious diseases and the delivery of health care. Clin Infect Dis 32 4 (2001) 605-611
104. Binkley S., Fishman N.O., LaRosa L.A., et al. Comparison of unit-specific and hospital-wide antibiograms: potential implications for selection of empirical antimicrobial therapy. Infect Control Hosp Epidemiol 27 7 (2006) 682-687
105. Leibovici L., Paul M., Poznanski O., et al. Monotherapy versus beta-lactam-aminoglycoside combination treatment for gram-negative bacteremia: a prospective, observational study. Antimicrob Agents Chemother 41 5 (1997) 1127-1133
106. Paul M., Benuri-Silbiger I., Soares-Weiser K., et al. Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials. BMJ 328 7441 (2004) 668
107. Safdar N., Handelsman J., and Maki D.G. Does combination antimicrobial therapy reduce mortality in gram-negative bacteraemia? A meta-analysis. Lancet Infect Dis 4 8 (2004) 519-527
108. Vidal F., Mensa J., Almela M., et al. Epidemiology and outcome of Pseudomonas aeruginosa bacteremia, with special emphasis on the influence of antibiotic treatment: analysis of 189 episodes. Arch Intern Med 156 18 (1996) 2121-2126
109. Bliziotis I.A., Samonis G., Vardakas K.Z., et al. Effect of aminoglycoside and beta-lactam combination therapy versus beta-lactam monotherapy on the emergence of antimicrobial resistance: a meta-analysis of randomized, controlled trials. Clin Infect Dis 41 2 (2005) 149-158
110. Gerding D.N., Larson T.A., Hughes R.A., et al. Aminoglycoside resistance and aminoglycoside usage: ten years of experience in one hospital. Antimicrob Agents Chemother 35 7 (1991) 1284-1290
111. Young E.J., Sewell C.M., Koza M.A., et al. Antibiotic resistance patterns during aminoglycoside restriction. Am J Med Sci 290 6 (1985) 223-227